We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

46 hedge funds and large institutions have $344M invested in Autolus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 4

250% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 6

31% more funds holding

Funds holding: 35 → 46 (+11)

2.49% more ownership

Funds ownership: 45.05% → 47.54% (+2.5%)

40% less capital invested

Capital invested by funds: $569M → $344M (-$225M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
46
Holders Change
+11
Holders Change %
+31.43%
% of All Funds
1%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
21
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Capital World Investors
Capital World Investors
California
+$23.8M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$14.4M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.36M
4
Millennium Management
Millennium Management
New York
+$7.1M
5
Marshall Wace
Marshall Wace
United Kingdom
+$6.32M

Top Sellers

1
WIM
Woodford Investment Management
United Kingdom
-$10M
2
CAM
Cormorant Asset Management
Massachusetts
-$3.35M
3
William Blair & Company
William Blair & Company
Illinois
-$378K
4
SFM
Sphera Funds Management
Israel
-$345K
5
AI
Alphabet Inc
California
-$329K
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
26
Laurion Capital Management
New York
$730K +$1.01M +45,314 New
BG
27
Bellevue Group
Switzerland
$547K +$760K +34,000 New
Allianz Asset Management
28
Allianz Asset Management
Germany
$483K -$207K -9,245 -24%
YCMGA
29
York Capital Management Global Advisors
New York
$390K +$541K +24,200 New
TD Asset Management
30
TD Asset Management
Ontario, Canada
$342K +$239K +10,680 +101%
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$323K +$306K +13,700 +215%
VEA
32
Virtus ETF Advisers
New York
$279K +$199K +8,877 +105%
Deutsche Bank
33
Deutsche Bank
Germany
$196K +$271K +12,129 +13,184%
Bank of Montreal
34
Bank of Montreal
Ontario, Canada
$193K – – –
Geode Capital Management
35
Geode Capital Management
Massachusetts
$182K +$34K +1,521 +16%
Walleye Trading
36
Walleye Trading
New York
$170K +$236K +10,556 New
Walleye Capital
37
Walleye Capital
New York
$168K +$233K +10,431 New
UBS Group
38
UBS Group
Switzerland
$52K +$72.4K +3,238 New
ED
39
Exane Derivatives
France
$49.7K +$69.1K +3,088 New
Bank of America
40
Bank of America
North Carolina
$24K +$32.7K +1,462 +3,111%
Wells Fargo
41
Wells Fargo
California
$11K +$8.95K +400 +133%
PCM
42
Prelude Capital Management
New York
$9K +$4.54K +203 +52%
Citigroup
43
Citigroup
New York
$7K +$4.45K +199 +75%
Daiwa Securities Group
44
Daiwa Securities Group
Japan
$2K – – –
Legal & General Group
45
Legal & General Group
United Kingdom
$2K +$2.24K +100 +217%
Barclays
46
Barclays
United Kingdom
$1K -$32.5K -1,455 -97%
William Blair & Company
47
William Blair & Company
Illinois
– -$378K -12,000 Closed
Goldman Sachs
48
Goldman Sachs
New York
– -$274K -8,720 Closed
TRCT
49
Tower Research Capital (TRC)
New York
– -$96K -3,041 Closed
Morgan Stanley
50
Morgan Stanley
New York
– -$1K -27 Closed
1
2

AUTL Hedge Fund Activity: Q2 2019 in Review

46 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q2 2019, worth a combined $344M — down 40% from $569M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AUTL positions and 4 closed out — a net gain of 11 holders — while 21 added to existing stakes and 6 trimmed.

The largest buyer was Capital World Investors, adding an estimated $23.8M. The largest seller was Woodford Investment Management, cutting an estimated $10M.

  • 46 institutional investors held Autolus Therapeutics (AUTL) as of Q2 2019, up from 35 in Q1 2019.
  • Funds reported $344M of Autolus Therapeutics stock for Q2 2019, down 40% quarter-over-quarter.
  • 15 funds opened new Autolus Therapeutics positions in Q2 2019 and 4 closed out, a net change of +11 holders.
  • The largest Autolus Therapeutics buyer in Q2 2019 was Capital World Investors, an estimated $23.8M added.
  • The largest Autolus Therapeutics seller in Q2 2019 was Woodford Investment Management, an estimated $10M sold.

Based on aggregated 13F filings for Q2 2019.